Skip to main content
Paul Bunn, MD, Oncology, Aurora, CO, University of Colorado Hospital

PaulBunnMD

Oncology Aurora, CO

Hematologic Oncology, Thoracic Cancer

James Dudley Professor of Lung Cancer Research Univ of COlorado

Dr. Bunn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Bunn's full profile

Already have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Medical Oncology, 1973 - 1976
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1971 - 1973
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1971

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 1984 - 2025
  • MD State Medical License
    MD State Medical License 1973 - 1986
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Fellow (FASCO) American Society of Clinical Oncologists, 2007
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • NOS Spring Membership Conference - Critical Transformations in the Practice of Oncology 
    Nevada Oncology Society (NOS), Las Vegas, Nevada - 5/9/2013

Press Mentions

  • Verastem Oncology Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
    Verastem Oncology Reports Second Quarter 2021 Financial Results and Highlights Recent Company ProgressAugust 2nd, 2021
  • With GlaxoSmithKline in the Rearview Mirror, Abbas Hussain Is Ready to Lead a Biotech of His Own; Doug Treco Scores First CEO Job Since Ra Pharma Buyout
    With GlaxoSmithKline in the Rearview Mirror, Abbas Hussain Is Ready to Lead a Biotech of His Own; Doug Treco Scores First CEO Job Since Ra Pharma BuyoutJune 25th, 2021
  • Verastem Oncology Appoints Paul Bunn, M.D., and Lesley Solomon to Board of Directors
    Verastem Oncology Appoints Paul Bunn, M.D., and Lesley Solomon to Board of DirectorsJune 24th, 2021
  • Join now to see all

Professional Memberships

Hospital Affiliations